Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2016

Dec 19, 2019

SELL
N/A
-326 Closed
0 $0
Q4 2015

Dec 19, 2019

BUY
N/A
326 New
326 $19,000
Q3 2015

Dec 19, 2019

SELL
N/A
-193 Closed
0 $0
Q2 2015

Dec 19, 2019

BUY
N/A
193
193 $13,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rothschild & CO Wealth Management Uk LTD Portfolio

Follow Rothschild & CO Wealth Management Uk LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Wealth Management Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Wealth Management Uk LTD with notifications on news.